Medical Equipment

Antimicrobial Resistance Diagnostics Market Projected To Surpass $6.23 Billion By 2030 At 7.1% CAGR

May 11, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Size Is Forecasted For The Antimicrobial Resistance Diagnostics Market By 2030 Based On Its 2026 Value?

The antimicrobial resistance diagnostics market has experienced significant growth in recent years. It is forecast to grow from $4.41 billion in 2025 to $4.74 billion in 2026, at a compound annual growth rate (CAGR) of 7.5%. The market’s historical expansion can be linked to the rising incidence of antibiotic-resistant infections, the persistent use of traditional culture-based diagnostics, an increase in hospital-acquired infections, greater understanding of antimicrobial stewardship, and the enlargement of clinical microbiology laboratories.

The antimicrobial resistance diagnostics market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $6.23 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. This expansion during the forecast period is largely due to advancements in PCR and NGS diagnostic technologies, increased government funding for AMR surveillance programs, a growing embrace of rapid diagnostic tests, an uptick in pharmaceutical and biotechnology research, and the incorporation of data-driven decision support tools. Key trends anticipated within this period involve the increasing adoption of rapid and point-of-care AMR diagnostics, a heightened demand for targeted and personalized antimicrobial therapy, intensified surveillance of drug-resistant pathogens, an expansion of molecular and genomic-based diagnostic testing, and the reinforcement of hospital infection control and stewardship programs.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25696&type=smp

Which Core Factors Are Supporting The Expansion Of The Antimicrobial Resistance Diagnostics Market?

The increasing occurrence of infections resistant to drugs is anticipated to drive the expansion of the antimicrobial resistance diagnostics market in the future. Such infections develop when bacteria, viruses, fungi, or parasites evolve ways to withstand medications that previously worked, rendering standard treatments ineffective and making these infections more challenging to manage. This escalating prevalence of drug-resistant infections stems from the excessive use of antibiotics in agriculture, where small amounts of antimicrobials are regularly incorporated into animal feed, fostering resistance that can then transfer to people via the food chain. Tools for diagnosing antimicrobial resistance, including quick genetic tests and culture-based sensitivity evaluations, are crucial in countering the rising incidence of drug-resistant infections. They achieve this by allowing for the prompt detection of resistant disease-causing agents, informing specific treatment approaches, and lessening the inappropriate use of wide-ranging antibiotics. As an illustration, in November 2024, the UK Health Security Agency (UKHSA), a government body located in the UK, indicated that severe antibiotic-resistant infections in England climbed from 58,224 in 2022 to an estimated 66,730 in 2023. Concurrently, antibiotic consumption saw an increase to 2.4% in 2023 from 2022. Consequently, the increasing frequency of drug-resistant infections is fueling the expansion of the antimicrobial resistance diagnostics market.

Which Segment Groups Define The Antimicrobial Resistance Diagnostics Market Landscape?

The antimicrobial resistance diagnostics market covered in this report is segmented –

1) By Product Type: Kits And Reagents, Instruments And Consumables

2) By Pathogen: Drug-Resistant Streptococcus Pneumoniae (DRSP), Drug Resistant Campylobacter (DRC), Clostridium Difficile (CD), Methicillin Resistant Staphylococcus Aureus (MRSA), Drug Resistant Neisseria Gonorrhoeae (DRNG), Drug Resistant Salmonella (DRntS), Other Pathogens

3) By Technology: Microbiology Culture, Immunoassay, PCR (Polymerase Chain Reaction), NGS (Next-Generation Sequencing), Mass Spectrometry, Rapid And Point Of Care, Other Technologies

4) By End-User: Hospitals And Clinics, Diagnostics Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits And Reagents: Deoxyribonucleic Acid (DNA) Extraction Kits, Ribonucleic Acid (RNA) Extraction Kits, Polymerase Chain Reaction (PCR) Reagents, Immunoassay Reagents, Stains And Dyes, Culture Media

2) By Instruments And Consumables: Polymerase Chain Reaction (PCR) Machines, Ultraviolet-Visible (UV-Vis) Spectrophotometers, Next-Generation Sequencing (NGS) Systems, Microarray Scanners, Automated Liquid Handlers, Sample Collection Tubes And Swabs

What Trends Are Influencing The Antimicrobial Resistance Diagnostics Market?

Leading companies within the antimicrobial resistance (AMR) diagnostics market are increasingly focusing on utilizing innovative technologies, such as point-of-care antimicrobial-susceptibility testing (AST) systems, to improve diagnostic speed, accuracy, and the effectiveness of antimicrobial stewardship. Point-of-care antimicrobial-susceptibility testing (AST) refers to quick, patient-side tests that determine which antibiotics are effective against an infection, enabling clinicians to rapidly choose targeted and effective treatments. For example, in June 2023, Sysmex Corporation, a Japan-based provider of in-vitro diagnostic solutions, unveiled the PA-100 AST System. This rapid point-of-care AST platform is designed to detect bacterial presence and ascertain antimicrobial susceptibility in urine samples within approximately 30 minutes. The system incorporates microfluidic single-cell analysis, provides near-patient testing capabilities, and automatically reports susceptibility outcomes. Ultimately, the PA-100 AST System enhances clinical decision-making, decreases unnecessary antibiotic prescriptions, and supports the delivery of timely, targeted therapy to combat antimicrobial resistance.

Who Are The Companies Shaping The Antimicrobial Resistance Diagnostics Market Landscape?

Major companies operating in the antimicrobial resistance diagnostics market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Becton Dickinson And Company, bioMerieux SA, Sysmex Corporation, Bio Rad Laboratories Inc, QIAGEN NV, Seegene Inc, Alifax S r l, Accelerate Diagnostics Inc, Molsid SAS, Genetic Signatures Limited, iFAST Diagnostics Ltd, Astek Diagnostics Inc, OpGen Inc, T2 Biosystems, Jiangsu Medomics Medical Technology Co Ltd, Cepheid, Luminex Corporation, Bruker Corporation, Hologic Inc

Access The Complete Antimicrobial Resistance Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/antimicrobial-resistance-diagnostics-global-market-report

Which Region Leads The Antimicrobial Resistance Diagnostics Market By Size?

North America was the largest region in the antimicrobial resistance diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Antimicrobial Resistance Diagnostics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=25696&type=smp

Browse Through More Reports Similar to the Global Antimicrobial Resistance Diagnostics Market 2026, By The Business Research Company

Sleep Apnea Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleep-apnea-devices-global-market-report

Sleep Tech Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleep-tech-devices-global-market-report

Sinus Dilation Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/sinus-dilation-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795